China Universal Asset Management Company’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$673K	Buy	30,256 +2,688	+10%	+$64.2K	0.05%	238
2025 Q4	$736K	Sell	27,568 -2,005	-7%	-$47.9K	0.06%	213
2025 Q3	$631K	Sell	29,573 -4,041	-12%	-$95.6K	0.05%	221
2025 Q2	$725K	Buy	33,614 +159	+0.5%	+$2.96K	0.07%	211
2025 Q1	$556K	Sell	33,455 -1,826	-5%	-$33.2K	0.05%	240
2024 Q4	$647K	Buy	35,281 +3,378	+11%	+$54.5K	0.06%	216
2024 Q3	$491K	Buy	31,903 +12,493	+64%	+$208K	0.05%	220
2024 Q2	$315K	Sell	19,410 -12,244	-39%	-$198K	0.04%	185
2024 Q1	$585K	Buy	31,654 +12,669	+67%	+$314K	0.07%	170
2023 Q4	$594K	Buy	18,985 +14,783	+352%	+$353K	0.12%	135
2023 Q3	$87.6K	Buy	4,202 +2,070	+97%	+$56.2K	0.03%	201
2023 Q2	$51.1K	Sell	2,132 -66	-3%	-$1.47K	0.02%	189
2023 Q1	$41.4K	Buy	2,198 +553	+34%	+$10.5K	0.01%	164
2022 Q4	$26.2K	Buy	1,645 +130	+9%	+$2.03K	0.01%	162
2022 Q3	$25K	Buy	+1,515	New	+$24.5K	0.01%	143